Fluorescence lifetime spectroscopy for guided therapy of brain tumors

NeuroImage

Volumn 54, Issue SUPPL. 1, 2011, Pages

  Butte, Pramod V ^a   Mamelak, Adam N ^a   Nuno, Miriam ^a   Bannykh, Serguei I ^a   Black, Keith L ^a   Marcu, Laura ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b University of California Davis   (United States)

Author keywords

Glioma; In vivo diagnosis; Time resolved fluorescence spectroscopy

Indexed keywords

ARTICLE; BRAIN CORTEX; BRAIN SURGERY; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FLUORESCENCE IMAGING; FLUORESCENCE SPECTROSCOPY; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TIME RESOLVED LASER INDUCED FLUORESCENCE SPECTROSCOPY; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; TUMOR DIFFERENTIATION; WHITE MATTER;

BRAIN NEOPLASMS; GLIOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

EID: 78650824541     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.11.001     Document Type: Article

References (60)

1. Andersson-Engels S., Johansson J., Stenram U., Svanberg K., Svanberg S. Time-resolved laser-induced fluorescence spectroscopy for enhanced demarcation of human atherosclerotic plaques. J. Photochem. Photobiol. B 1990, 4:363-369.
2. Baron A.E. Misclassification among methods used for multiple group discrimination-the effects of distributional properties. Stat. Med. 1991, 10:757-766.
3. Bello A.L. Misclassification among methods used for multiple group discrimination-the effects of distributional properties. Stat. Med. 1992, 11:1623-1624.
4. Berger M.S. Malignant astrocytomas: surgical aspects. Semin. Oncol. 1994, 21:172-185.
5. Beychok S., Tyuma I., Benesch R.E., Benesch R. Optically active absorption bands of hemoglobin and its subunits. J. Biol. Chem. 1967, 242:2460-2462.
6. Bottiroli G., Croce A.C., Locatelli D., Marchesini R., Pignoli E., Tomatis S., Cuzzoni C., Di Palma S., Dalfante M., Spinelli P. Natural fluorescence of normal and neoplastic human colon: a comprehensive "ex vivo" study. Lasers Surg. Med. 1995, 16:48-60.
7. Bottiroli G., Croce A.C., Locatelli D., Nano R., Giombelli E., Messina A., Benericetti E. Brain tissue autofluorescence: an aid for intraoperative delineation of tumor resection margins. Cancer Detect. Prev. 1998, 22:330-339.
8. Brandes A.A., Tosoni A., Franceschi E., Reni M., Gatta G., Vecht C. Glioblastoma in adults. Crit. Rev. Oncol. Hematol. 2008, 67:139-152.
9. Butte P.V., Pikul B.K., Hever A., Yong W.H., Black K.L., Marcu L. Diagnosis of meningioma by time-resolved fluorescence spectroscopy. J. Biomed. Opt. 2005, 10:064026.
10. Butte P.V., Fang Q., Jo J.A., Yong W.H., Pikul B.K., Black K.L., Marcu L. Intra-operative delineation of primary brain tumors using time-resolved fluorescence spectroscopy. J. Biomed. Opt. 2010, 15.
11. Byar, D.P., Green, S., Strike, T.A.,Walker, M.D., 1983. Prognostic factors for malignant glioma. Oncology of the nervous system. Martinus Nijhoff, Boston, pp. 379-395.
12. Chung Y.G., Schwartz J.A., Gardner C.M., Sawaya R.E., Jacques S.L. Diagnostic potential of laser-induced autofluorescence emission in brain tissue. J. Korean Med. Sci. 1997, 12:135-142.
13. Croce A.C., Fiorani S., Locatelli D., Nano R., Ceroni M., Tancioni F., Giombelli E., Benericetti E., Bottiroli G. Diagnostic potential of autofluorescence for an assisted intraoperative delineation of glioblastoma resection margins. Photochem. Photobiol. 2003, 77:309-318.
14. Cubeddu R., Ramponi R., Liu W.Q., Docchio F. Time-gated fluorescence spectroscopy of the tumor localizing fraction of HpD in the presence of cationic surfactant. Photochem. Photobiol. 1989, 50:157-163.
15. Cubeddu R., Taroni P., Valentini G., Canti G. Use of time-gated fluorescence imaging for diagnosis in biomedicine. J. Photochem. Photobiol. B 1992, 12:109-113.
16. Cubeddu R., Pifferi A., Taroni P., Valentini G., Canti G. Tumor detection in mice by measurement of fluorescence decay time matrices. Opt. Lett. 1995, 20:2553.
17. Dickinson R.B., Wehry E.L. Time-resolved matrix-isolation fluorescence spectrometry of mixtures of polycyclic aromatic hydrocarbons. Anal. Chem. 1979, 51:778-780.
18. Ducray F., Dutertre G., Ricard D., Gontier E., Idbaih A., Massard C. Advances in adults' gliomas biology, imaging and treatment. Bull. Cancer 2010, 97:17-36.
19. Elson D., Requejo-Isidro J., Munro I., Reavell F., Siegel J., Suhling K., Tadrous P., Benninger R., Lanigan P., McGinty J., Talbot C., Treanor B., Webb S., Sandison A., Wallace A., Davis D., Lever J., Neil M., Phillips D., Stamp G., French P. Time-domain fluorescence lifetime imaging applied to biological tissue. Photochem. Photobiol. Sci. 2004, 3:795-801.
20. Fang Q., Papaioannou T., Jo J.A., Vaitha K., Marcu L. Time-domain laser-induced fluorescence spectroscopy apparatus for clinical diagnostics. Rev. Sci. Instrum. 2004, 75:151-162.
21. Fazekas J.T. Treatment of grades I and II brain astrocytomas. The role of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1977, 2:661-666.
22. Haj-Hosseini N., Richter J., Andersson-Engels S., Wardell K. Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid. Lasers Surg. Med. 2010, 42:9-14.
23. Hartmann C., Meyer J., Balss J., Capper D., Mueller W., Christians A., Felsberg J., Wolter M., Mawrin C., Wick W., Weller M., Herold-Mende C., Unterberg A., Jeuken J.W., Wesseling P., Reifenberger G., von Deimling A. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1, 010 diffuse gliomas. Acta Neuropathol. 2009, 118:469-474.
24. Jameson D.M., Thomas V., Zhou D.M. Time-resolved fluorescence studies on NADH bound to mitochondrial malate dehydrogenase. Biochim. Biophys. Acta 1989, 994:187-190.
25. Jo J.A., Fang Q., Papaioannou T., Marcu L. Fast model-free deconvolution of fluorescence decay for analysis of biological systems. J. Biomed. Opt. 2004, 9:743-752.
26. Jo J.A., Fang Q., Papaioannou T., Qiao J.H., Fishbein M.C., Dorafshar A., Reil T., Baker D., Freischlag J., Marcu L. Novel methods of time-resolved fluorescence data analysis for in-vivo tissue characterization: application to atherosclerosis. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2004, 2:1372-1375.
27. Jo J.A., Fang Q., Papaioannou T., Qiao J.H., Fishbein M.C., Beseth B., Dorafshar A.H., Reil T., Baker D., Freischlag J., Marcu L. Application of the laguerre deconvolution method for time-resolved fluorescence spectroscopy to the characterization of atherosclerotic plaques. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2005, 6:6559-6562.
28. Jo J.A., Marcu L., Fang Q., Papaioannou T., Qiao J.H., Fishbein M.C., Beseth B., Dorafshar A.H., Reil T., Baker D., Freischlag J. New methods for time-resolved fluorescence spectroscopy data analysis based on the Laguerre expansion technique-applications in tissue diagnosis. Methods Inf. Med. 2007, 46:206-211.
29. Konig K., Berns M.W., Tromberg B.J. Time-resolved and steady-state fluorescence measurements of beta-nicotinamide adenine dinucleotide-alcohol dehydrogenase complex during UVA exposure. J. Photochem. Photobiol. B 1997, 37:91-95.
30. Kriegeskorte N., Simmons W.K., Bellgowan P.S., Baker C.I. Circular analysis in systems neuroscience: the dangers of double dipping. Nat. Neurosci. 2009, 12:535-540.
31. Lakowicz J.R. Principles of fluorescence spectroscopy 2006, Springer, New York. 3rd ed.
32. Lin W.C., Toms S.A., Johnson M., Jansen E.D., Mahadevan-Jansen A. In vivo brain tumor demarcation using optical spectroscopy. Photochem. Photobiol. 2001, 73:396-402.
33. Lin W.C., Mahadevan-Jansen A., Johnson M.D., Weil R.J., Toms S.A. In vivo optical spectroscopy detects radiation damage in brain tissue. Neurosurgery 2005, 57:518-525. discussion 518-525.
34. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114:97-109.
35. Majumder S.K., Gebhart S., Johnson M.D., Thompson R., Lin W.C., Mahadevan-Jansen A. A probability-based spectroscopic diagnostic algorithm for simultaneous discrimination of brain tumor and tumor margins from normal brain tissue. Appl. Spectrosc. 2007, 61:548-557.
36. Marcu L., Fishbein M.C., Maarek J.M., Grundfest W.S. Discrimination of human coronary artery atherosclerotic lipid-rich lesions by time-resolved laser-induced fluorescence spectroscopy. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1244-1250.
37. Marcu L., Jo J.A., Butte P.V., Yong W.H., Pikul B.K., Black K.L., Thompson R.C. Fluorescence lifetime spectroscopy of glioblastoma multiforme. Photochem. Photobiol. 2004, 80:98-103.
38. Muller P.J., Wilson B.C. Photodynamic therapy of brain tumors-a work in progress. Lasers Surg. Med. 2006, 38:384-389.
39. Nithipatikom K., McGown L.B. Five- and six-component determinations using phase-resolved fluorescence spectroscopy and synchronous excitation. Appl. Spectrosc. 1987, 41:395-399.
40. Papaioannou T., Preyer N., Fang Q., Carnohan M., Ross R., Brightwell A., Cottone G., Jones L., Marcu L. Effects of fiber-optic probe design and probe-to-target distance on diffuse reflectance measurements of turbid media: an experimental and computational study at 337nm. Appl. Opt. 2004, 43:2846-2860.
41. Poon W.S., Schomacker K.T., Deutsch T.F., Martuza R.L. Laser-induced fluorescence: experimental intraoperative delineation of tumor resection margins. J. Neurosurg. 1992, 76:679-686.
42. Rausch J.R., Kelley K. A comparison of linear and mixture models for discriminant analysis under nonnormality. Behav. Res. Methods 2009, 41:85-98.
43. Robins H.I., Lassman A.B., Khuntia D. Therapeutic advances in malignant glioma: current status and future prospects. Neuroimaging Clin. N. Am. 2009, 19:647-656.
44. Rosato N., Mei G., Finazzi-Agro A., Tancini B., Borri-Voltattorni C. Time-resolved extrinsic fluorescence of aromatic-L-amino-acid decarboxylase. Biochim. Biophys. Acta 1989, 996:195-198.
45. Sanai N., Berger M.S. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008, 62:753-764. discussion 264-756.
46. Siegel J., Elson D.S., Webb S.E., Lee K.C., Vlandas A., Gambaruto G.L., Leveque-Fort S., Lever M.J., Tadrous P.J., Stamp G.W., Wallace A.L., Sandison A., Watson T.F., Alvarez F., French P.M. Studying biological tissue with fluorescence lifetime imaging: microscopy, endoscopy, and complex decay profiles. Appl. Opt. 2003, 42:2995-3004.
47. Smith J.S., Chang E.F., Lamborn K.R., Chang S.M., Prados M.D., Cha S., Tihan T., Vandenberg S., McDermott M.W., Berger M.S. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J. Clin. Oncol. 2008, 26:1338-1345.
48. Sud D., Zhong W., Beer D.G., Mycek M.A. Time-resolved optical imaging provides a molecular snapshot of altered metabolic function in living human cancer cell models. Opt. Express 2006, 14:4412-4426.
49. Sun Y., Liu R., Elson D.S., Hollars C.W., Jo J.A., Park J., Marcu L. Simultaneous time- and wavelength-resolved fluorescence spectroscopy for near real-time tissue diagnosis. Opt. Lett. 2008, 33:630-632.
50. Sun Y., Phipps J., Elson D.S., Stoy H., Tinling S., Meier J., Poirier B., Chuang F.S., Farwell D.G., Marcu L. Fluorescence lifetime imaging microscopy: in vivo application to diagnosis of oral carcinoma. Opt. Lett. 2009, 34:2081-2083.
51. Svensson T., Andersson-Engels S., Einarsdottir M., Svanberg K. In vivo optical characterization of human prostate tissue using near-infrared time-resolved spectroscopy. J. Biomed. Opt. 2007, 12:014022.
52. Toms S.A., Lin W.C., Weil R.J., Johnson M.D., Jansen E.D., Mahadevan-Jansen A. Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity. Neurosurgery 2005, 57:382-391. discussion 382-391.
53. Umesh S., Tandon A., Santosh V., Anandh B., Sampath S., Chandramouli B.A., Sastry Kolluri V.R. Clinical and immunohistochemical prognostic factors in adult glioblastoma patients. Clin. Neuropathol. 2009, 28:362-372.
54. Vishwanath K., Pogue B., Mycek M.A. Quantitative fluorescence lifetime spectroscopy in turbid media: comparison of theoretical, experimental and computational methods. Phys. Med. Biol. 2002, 47:3387-3405.
55. Wagnieres G.A., Star W.M., Wilson B.C. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem. Photobiol. 1998, 68:603-632.
56. Watanabe T., Nakamura M., Kros J.M., Burkhard C., Yonekawa Y., Kleihues P., Ohgaki H. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Acta Neuropathol. 2002, 103:267-275.
57. Widhalm G., Wolfsberger S., Minchev G., Woehrer A., Krssak M., Czech T., Prayer D., Asenbaum S., Hainfellner J.A., Knosp E. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer 2010, 116:1545-1552.
58. Yan H., Bigner D.D., Velculescu V., Parsons D.W. Mutant metabolic enzymes are at the origin of gliomas. Cancer Res. 2009, 69:9157-9159.
59. Yaroslavsky A.N., Schulze P.C., Yaroslavsky I.V., Schober R., Ulrich F., Schwarzmaier H.J. Optical properties of selected native and coagulated human brain tissues in vitro in the visible and near infrared spectral range. Phys. Med. Biol. 2002, 47:2059-2073.
60. Yong W.H., Butte P.V., Pikul B.K., Jo J.A., Fang Q., Papaioannou T., Black K., Marcu L. Distinction of brain tissue, low grade and high grade glioma with time-resolved fluorescence spectroscopy. Front. Biosci. 2006, 11:1255-1263.